Reuters exclusively reports Latin America poised to benefit as U.S. raises exports of COVID-19 shots

Reuters exclusively reported that Latin America is poised to receive millions of U.S-made COVID-19 shots in the coming weeks as the United States emerges as a top exporter of vaccines against the novel coronavirus. The United States is considering prioritizing countries within its own hemisphere for the 80 million domestically-made vaccine doses it has pledged to send abroad. Pfizer Inc has begun exporting millions of its U.S made shots largely to countries in Central and South America, sources told Reuters.

Article Tags
Topics of Interest: Health
Type: Reuters Best
Sectors: Pharmaceuticals & Healthcare
Regions: Americas
Win Types: Exclusivity
Story Types: Exclusive / Scoop
Media Types: Text
Customer Impact: Important Regional Story
Sign up for email updates

Sign up for email updates